logo
logo

Swing Therapeutics announced it raised $9.19 Million in an initial filing from an offering of $9.25 Million

Swing Therapeutics announced it raised $9.19 Million in an initial filing from an offering of $9.25 Million

07/26/22, 7:16 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan francisco
Money raised
$9.19 million
Industry
biotechnology

Company Info

Company
Swing Therapeutics
Location
548 market street, #63989
san francisco, california, united states
Additional Info
Swing Therapeutics was founded in 2019 with the goal of developing digital treatments and services in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development of prescription-based digital therapies and services. Swing Therapeutics received FDA Breakthrough Device Designation for its digital therapy for fibromyalgia management. Its near-term goal is to validate its digital therapy and bring it to market as an FDA-cleared, prescription digital therapeutic. For more information visit swingtherapeutics.com.

Related People